UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer

Phase 1

Active, not recruiting

Conditions: Recurrent Breast Carcinoma
Stage IIIA Breast Cancer
Stage IIIC Breast Cancer
Stage III Breast Cancer
HER2 Negative Breast Carcinoma
Stage IIIB Breast Cancer
Stage IV Breast Cancer

Interventions: Biological: CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
Other: Laboratory Biomarker Analysis

First Posted Date: 2014-06-05

Last Posted Date: 2025-02-27

Lead Sponsor: University of Washington

Target Recruit Count: 42

Registration Number: NCT02157051

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Improving the Concentration of MR Contrast in the Arteries

Not Applicable

Completed

Conditions: Contrast Media
Magnetic Resonance Angiography

Interventions: Other: Standard Injection Rate
Other: Patient Tailored Injection Rate
Other: gadolinium contrast

First Posted Date: 2014-06-04

Last Posted Date: 2017-10-26

Lead Sponsor: University of Washington

Target Recruit Count: 26

Registration Number: NCT02155218

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Not Applicable

Terminated

Conditions: Recurrent Breast Carcinoma
Estrogen Receptor Positive
Stage IV Breast Cancer AJCC v6 and v7

Interventions: Procedure: Computed Tomography
Drug: F-18 16 Alpha-Fluoroestradiol
Drug: Fludeoxyglucose F-18
Other: Laboratory Biomarker Analysis
Procedure: Positron Emission Tomography

First Posted Date: 2014-05-29

Last Posted Date: 2021-06-30

Lead Sponsor: University of Washington

Target Recruit Count: 29

Registration Number: NCT02149173

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

ITT-5 Mechanisms of Spermatogenesis in Man

Phase 2

Withdrawn

Conditions: Gonadotropin Deficiency

Interventions: Drug: Testosterone 1% Gel
Drug: Acyline
Drug: HCG
Drug: placebo dutasteride
Drug: Ketoconazole
Drug: Dutasteride
Drug: placebo ketoconazole

First Posted Date: 2014-05-28

Last Posted Date: 2019-12-18

Lead Sponsor: University of Washington

Registration Number: NCT02147964

Locations: 🇺🇸
University of Washington Medical Center (Health Sciences), Seattle, Washington, United States

The Effects of Indocyanine Green Angiography (IGA) on Deep Inferior Epigastric Artery Perforator (DIEP) Flap Design and Post-Operative Fat Necrosis

Conditions: Breast Cancer

First Posted Date: 2014-05-22

Last Posted Date: 2016-03-24

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT02144961

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

A Primary Prevention Trial to Strengthen Child Attachment in a Native Community

Not Applicable

Completed

Conditions: Parent-child Interaction

Interventions: Behavioral: PFR Group
Behavioral: Resource & Referral Group

First Posted Date: 2014-05-15

Last Posted Date: 2021-09-02

Lead Sponsor: University of Washington

Target Recruit Count: 225

Registration Number: NCT02139332

Locations: 🇺🇸
MBIRI, Eagle Butte, South Dakota, United States

Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study

Not Applicable

Completed

Conditions: Multiple Sclerosis
Pain
Depression

Interventions: Behavioral: Collaborative Care (CC)

First Posted Date: 2014-05-13

Last Posted Date: 2017-12-06

Lead Sponsor: University of Washington

Target Recruit Count: 195

Registration Number: NCT02137044

Locations: 🇺🇸
University of Washington- Harborview Medical Center, Seattle, Washington, United States
🇺🇸
University of Washington Medicine MS Center, Seattle, Washington, United States
🇺🇸
University of Washington-Health Sciences Building, Seattle, Washington, United States

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

Not Applicable

Completed

Conditions: Cervical Cancer
Colon Cancer
Lymphoma
Malignant Neoplasm
Rectal Cancer
Breast Cancer
Leukemia
Melanoma

Interventions: Other: educational intervention
Behavioral: telephone-based intervention
Other: questionnaire administration

First Posted Date: 2014-05-02

Last Posted Date: 2016-03-09

Lead Sponsor: University of Washington

Target Recruit Count: 35

Registration Number: NCT02129049

Locations: 🇺🇸
Bozeman Deaconess Hospital, Bozeman, Montana, United States
🇺🇸
Columbia Basin Hematology and Oncology PLLC, Kennewick, Washington, United States
🇺🇸
SCCA at EvergreenHealth, Kirkland, Washington, United States

and more 8 locations

Accommodating for Residual Limb Fluid Volume Change

Completed

Conditions: Diurnal Residual Limb Fluid Volume Fluctuation

First Posted Date: 2014-04-28

Last Posted Date: 2020-11-04

Lead Sponsor: University of Washington

Target Recruit Count: 45

Registration Number: NCT02124876

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Influence of Socket Volume on Prosthesis Performance

Completed

Conditions: Lower Limb Amputation Below Knee (Injury)

First Posted Date: 2014-04-28

Last Posted Date: 2017-08-24

Lead Sponsor: University of Washington

Target Recruit Count: 9

Registration Number: NCT02124915

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy